BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 7839179)

  • 21. Difficulties in diagnosis and management of bipolar disorder: three case presentations.
    Brady KT
    J Clin Psychiatry; 2000; 61 Supp 13():32-7. PubMed ID: 11153810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of bipolar disorder in older adults.
    Sajatovic M
    Int J Geriatr Psychiatry; 2002 Sep; 17(9):865-73. PubMed ID: 12221662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective response to the anticonvulsant carbamazepine in manic-depressive illness: a case study.
    Post RM; Berrettini W; Uhde TW; Kellner C
    J Clin Psychopharmacol; 1984 Aug; 4(4):178-85. PubMed ID: 6432857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological issues in the treatment of bipolar disorder: focus on mood-stabilizing compounds.
    Potter WZ; Ketter TA
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S51-6. PubMed ID: 8500079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polypharmacy in bipolar I disorder.
    Solomon DA; Keitner GI; Ryan CE; Miller IW
    Psychopharmacol Bull; 1996; 32(4):579-87. PubMed ID: 8993078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature.
    Ketter TA; Pazzaglia PJ; Post RM
    J Clin Psychopharmacol; 1992 Aug; 12(4):276-81. PubMed ID: 1527232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug combinations of lithium: reasons and limitations].
    Lagomarsino AJ
    Acta Psiquiatr Psicol Am Lat; 1993 Dec; 39(4):319-25. PubMed ID: 8191909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National Institute of Mental Health Workshop Report on the Treatment of Bipolar Disorder.
    Prien RF; Rush AJ
    Biol Psychiatry; 1996 Aug; 40(3):215-20. PubMed ID: 8830955
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticonvulsants in the treatment of bipolar disorder.
    Keck PE; McElroy SL; Nemeroff CB
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):395-405. PubMed ID: 1422166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticonvulsants in affective disorders.
    Small JG
    Psychopharmacol Bull; 1990; 26(1):25-36. PubMed ID: 2196624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developments in mood stabilisers.
    Ferrier IN
    Br Med Bull; 2001; 57():179-92. PubMed ID: 11719917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
    Roick C; Ahrens B; Becker T
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticonvulsant therapy and suicide risk in affective disorders.
    Goodwin FK
    J Clin Psychiatry; 1999; 60 Suppl 2():89-93; discussion 111-6. PubMed ID: 10073394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
    Li X; Ketter TA; Frye MA
    J Affect Disord; 2002 May; 69(1-3):1-14. PubMed ID: 12103447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of response to divalproex and lithium.
    Bowden CL
    J Clin Psychiatry; 1995; 56 Suppl 3():25-30. PubMed ID: 7883739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of bipolar disorder.
    Griswold KS; Pessar LF
    Am Fam Physician; 2000 Sep; 62(6):1343-53, 1357-8. PubMed ID: 11011863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.